NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
10/31/2023
Back to search
Official data from USPTO
CLINICAL EFFECTS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
10/31/2023
Trademark type
Combined
Nice classes
3, 5
Filing date
01/29/2021
Registration date
08/23/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/23/2022
Last transaction
08/23/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/01/2021
First use in commerce
03/01/2021
Drawing code
3
Owner type
16
Owner location
Boise, ID, US
Examiner
MCDORMAN, ROGER THOMAS
Law office
L90
Current location
TMEG LAW OFFICE 109
Mark description
The mark consists of the terms "Clinical Effects" in a stylized font. The term "Clinical" is placed above the term "Effects". The terms are placed to the right of three horizontal bars and a dot placed to the right side of each bar. The left side of each bar together forms the appearance of a semi-circular shape, and the right end of each bar is rounded.
Holders and representatives
Holders
Meliorra, LLC
Representatives
Erica L. Tritt Erica L. Tritt
Technical classification
Nice Classes
Class 3Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Cosmetics
Class 5
Dietary and nutritional supplements
Publications
History of USPTO decisions and trademark events.
27 publications found
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
09/27/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/27/2023
ES7R
TEAS SECTION 7 REQUEST RECEIVED
02/13/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/23/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/23/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/19/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/16/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/14/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/13/2022
IUAF
USE AMENDMENT FILED
05/26/2022
EISU
TEAS STATEMENT OF USE RECEIVED
05/26/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/24/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/29/2022
PUBO
PUBLISHED FOR OPPOSITION
03/29/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/09/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/23/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/21/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/21/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/21/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/22/2021
GNRT
NON-FINAL ACTION E-MAILED
08/22/2021
CNRT
NON-FINAL ACTION WRITTEN
08/22/2021
DOCK
ASSIGNED TO EXAMINER
08/18/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/04/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/02/2021
NWAP
NEW APPLICATION ENTERED
02/02/2021
Continuous trademark protection
Get notified about every new filing that threatens CLINICAL EFFECTS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.